Mutat Res 2003, 526: 93–125.PubMed 6. López-Cima MF, González-Arriaga P, García-Castro L, Pascual T, Marrón MG, Puente XS, Tardón A: Nutlin-3 order polymorphisms in XPC, Seliciclib chemical structure XPD, XRCC1, and XRCC3 DNA repair genes
and lung cancer risk in a population of northern Spain. BMC Cancer 2007, 7: 162.CrossRefPubMed 7. Martinez-Balibrea E, Manzano JL, Martinez-Cardus A, Moran T, Cirauqui B, Catot S, Taron M, Abad A: Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan. Oncol Rep 2007, 17 (3) : 637–645.PubMed 8. Burri RJ, Stock RG, Cesaretti JA, Atencio DP, Peters S, Peters CA, Fan G, Stone NN, Ostrer H, Rosenstein BS: Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. Radiat Res 2008, 170 (1) : 49–59.CrossRefPubMed 9. McWilliams RR, Bamlet WR, Cunningham JM, Goode
EL, de Andrade M, Boardman LA, Petersen GM: Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 2008, 15;68 (12) : 4928–4935.CrossRef 10. Fontana L, Bosviel R, Delort L, Guy L, Chalabi N, Kwiatkowski F, Satih S, Rabiau N, Boiteux JP, Chamoux A, Bignon YJ, Bernard-Gallon DJ: DNA repair Apoptosis antagonist gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort. Anticancer Res 2008, 28 (3B) : 1853–1856.PubMed 11. Wang Z, Xu B, Lin D, Tan W, Leaw S, Hong X, Hu X: XRCC1 polymorphisms and severe toxicity in lung cancer Immune system patients treated with cisplatin-based chemotherapy in Chinese population. Lung Cancer 2008, 62 (1) : 99–104.CrossRefPubMed 12. Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, Vijayalekshmi RV, Madhavan J, Ankathil R: Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and
XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol 2008, 134 (6) : 645–652.CrossRefPubMed 13. Dufloth RM, Arruda A, Heinrich JK, Schmitt F, Zeferino LC: The investigation of DNA repair polymorphisms with histopathological characteristics and hormone receptors in a group of Brazilian women with breast cancer. Genet Mol Res 2008, 1;7 (3) : 574–582.CrossRef 14. Yen CY, Liu SY, Chen CH, Tseng HF, Chuang LY, Yang CH, Lin YC, Wen CH, Chiang WF, Ho CH, Chen HC, Wang ST, Lin CW, Chang HW: Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med 2008, 37 (5) : 271–277.CrossRefPubMed 15. Shall S, de Murcia G: Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat Res 2000, 460: 1–15.PubMed 16.